Far more MOUNJARO-handled patients who formulated anti-tirzepatide antibodies skilled hypersensitivity reactions or injection web page reactions than individuals who didn't develop these antibodies [see ADVERSE REACTIONS ].When you've got an coverage plan that may be taking part in an alternate funding program ("AFP") that requires you to apply for